Close Menu
The Startup Story
    Facebook X (Twitter) Instagram
    Sunday, May 18
    Trending
    • Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again
    • Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry
    • ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities
    • Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic
    • Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results
    • Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25
    • Intense Technologies Powers Ahead with 32 Percent Growth in Revenue YoY
    • Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India
    The Startup Story
    • Startup News
    • Business
    • Technology
    • National
    • World
    The Startup Story
    Home»English»Dr. R Ananthanarayanan appointed as the new CEO & Managing Director of Strides
    English

    Dr. R Ananthanarayanan appointed as the new CEO & Managing Director of Strides

    Arjun SinghBy Arjun SinghJanuary 10, 2020No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Ahmedabad (Newswire India) –Strides Pharma Science Limited (Strides) today announced that the Board of Directors (Board) of the Company have appointed Dr. R Ananthanarayanan as Chief Executive Officer (CEO) and Managing Director (MD) of Strides effective January 09, 2020.

    Dr. R Ananthanarayanan (Ananth) will succeed Arun Kumar, Founder, and the incumbent CEO &MD of the Company. Arun will transition his active responsibilities at Strides by the financial year ending March 31,2020, and will step into a strategic role as Chairman of the Board with effect from April 01, 2020.

    Ananth brings with him over three decades of top pedigree global pharmaceutical experience across both the technical and commercial functions. Until recently, Ananth was the Global Chief Operating Officer at Cipla Limited, where he was responsible for the company’s generics business in regulated markets and branded generics in emerging markets. He was also driving their API business, biosimilars, complex drug-device combinations, including 505(b)(2) products.

    Prior to Cipla, Ananth was the President & CEO ofGlobal APIs, Biologics, &Medis Generics B2B division at Teva Pharmaceutical Industries Ltd in the US,managing multi-billion P&L responsibility.He has also held leadership roles at Dr. Reddy’s Laboratories, Piramal Healthcare (Formerly Nicholas Piramal), Galpharm International, UK (Acquired by Perrigo Group), and Zydus Cadila.

    Ananth is a Graduate in Pharmaceutical Sciences and earned his Ph.D. in Pharmaceutical Technology from the University of Mumbai, India. He hasalso been a member of the Board of Advisors at the School of Pharmacy and Health Sciences at Fairleigh Dickinson University, New Jersey.

    Ananth’s appointment at Strides comes at the time when the company has concluded its reset strategy to drive profitable future growth on the back of a stronger balance sheet. The Board strongly believes that Ananth’s exceptional global techno-commercial experience and leadership stature in managing the P&Ls of large global pharmaceutical companies will multiply the company’s commitment to creating perpetual value for all its stakeholders.

    Expressing confidence in the Board’s choice , Arun Kumar, remarked, “Having founded Strides and led the company for close to 30 years, I believe the time is right for me to step aside and have Ananth lead it to greater heights. Ananth brings in the right balance of technical and commercial expertise, and I am confident that Strides will significantly benefit from his leadership experience, industry perspective, technical knowledge, and business acumen. As he takes on the mantle of Strides, I will now move to a more strategic role as the Chairman of the Board and will dedicate time to Strides’ newly announced investments in Biotech and sterile injectables.” 

    Dr. R Ananthanarayanan,the new CEO & MD of Strides, commented, “It’s my privilege and honor to take over as the CEO &MD of Strides, and I would like to appreciate the confidence reposed in me by Arun and the Board. These are exciting times for Strides, and I look forward to partner with all the global colleagues to ensure successful realization of the Stridesstrategic objectives while ensuring that we consistently deliver quality medicines to all our patients globally.”

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleSBM Bank (India) & Pay Nearby sign up to offer ‘open banking’ to the masses
    Next Article India’s best/top-selling woman author Savi Sharma unveils her latest book ‘Stories We Never Tell’ at Surat
    Arjun Singh
    • Website

    Related Posts

    Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again

    May 17, 2025

    Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry

    May 17, 2025

    ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities

    May 17, 2025

    Comments are closed.

    Latest Post

    Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again

    May 17, 2025

    Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry

    May 17, 2025

    ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities

    May 17, 2025

    Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic

    May 17, 2025

    Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results

    May 17, 2025

    Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25

    May 17, 2025

    Intense Technologies Powers Ahead with 32 Percent Growth in Revenue YoY

    May 17, 2025

    Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India

    May 17, 2025

    EassyLife Honoured as ‘Best Brand of the Year in E-commerce – Services’ by CNBC TV18

    May 17, 2025
    Categories
    • Alieus Hedge Fund
    • Automobile
    • Awards with Asia Insurance Review
    • Bajaj Allianz General Insurance
    • Business
    • Business News
    • Chairperson & MD
    • Demat Account
    • Design
    • Education
    • English
    • ENTERTAINMENT
    • Events
    • Fashion
    • FATx Coin
    • Feb-2025
    • Finance
    • Health
    • Hindi
    • home loan
    • Home Loan EMI Calculator
    • Issues Rs 100 Crore Bond
    • Launching Worldwide
    • Lifestyle
    • Municipal Corporation
    • National
    • NW Draft
    • Opinion
    • Pallavi Jha
    • Photography
    • Piramal Finance
    • Piramal Finance Home Loan EMI Calculator
    • PNN News
    • Press Release
    • Rajkot
    • Sports
    • Startup News
    • Tech
    • Technology
    • Techonology
    • Travel
    • Uncategorized
    • Walchand PeopleFirst
    • World
    • एजुकेशन
    • नेशनल
    • बिज़नस
    • लाइफस्टाइल
    • हेल्थ
    Copyright 2025 © Designed by The Startup Story.

    Type above and press Enter to search. Press Esc to cancel.